Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of Cocaine Addiction Using mGluR5 PET and fMRI
NCT03471182Phase 1Completed
- Sponsor
- Yale University
- Start
- Feb 2018
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Yale University. Primary endpoints: Regional Availability of Metabotropic Glutamate Type-5 Receptors (mGluR5), Functional Brain Network Engagement Associated With Response Inhibition and 1 more. Started Feb 2018; status: completed.
Beyond the preview
Go deeper on NCT03471182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03471182.